Author

A. Sastre-Perona

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Approach:experimental assay· 2 Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:gene regulatory network inference· 1 Approach:statistical model· 1

Frequent Co-Authors

A. Garcia-Guede· 1 shared B. Aranda Orgilles· 1 shared C. Rodriguez· 1 shared C. Rodriguez-Antolin· 1 shared D. Sanchez-Cabrero· 1 shared I. Aifantis· 1 shared I. Ibanez de Caceres· 1 shared J. de Castro· 1 shared

Activity by Year

2020-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Garcia-Guede

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintAug 18, 2021

SOX2-phosphorylation toggles a bistable differentiation-switch in squamous cell carcinoma

S. Hoang-Phou, A. Sastre-Perona, M. Abbruzzese…·M. Schober

This paper identifies a mechanism by which SOX2-phosphorylation toggles a bistable differentiation switch in squamous cell carcinoma, enabling tumor-propagating cells to transition from self-renewal to differentiation.

DOI 10.1101/2021.08.18.455699

humanbulk RNA-seq

𝕏 PostBluesky

Cancer BiologybioRxivJan 15, 2020

A novel role for the tumor suppressor gene ITF2 in lung tumorigenesis and chemotherapy response

O. Pernia, A. Sastre-Perona, C. Rodriguez-Antolin…·I. Ibanez de Caceres

This study identifies ITF2 as a tumor suppressor involved in cisplatin resistance and chemotherapy response in epithelial tumors, with potential as a biomarker and therapeutic target.

DOI 10.3390/cancers12040786

humanbulk RNA-seq

𝕏 PostBluesky